GLP-1 Drugs: Morgan Stanley analysts have recently noted a significant shift in the treatment of diabetes, which could potentially boost the market for weight-loss drugs. The focus is now intensifying on weight management for patients with diabetes, which is expected to enhance the sales of GLP-1 drugs. GLP-1 (glucagon-like peptide-1) drugs are a type of medication for people with type 2 diabetes. They work by … Continue reading GLP-1 Drugs Gain Traction as Diabetes Treatment Focuses on Weight Management